Can You Screen Yourself for AFib by Feeling Your Own Pulse?
A long-standing guideline recommendation for AFib screening finally got tested against a real ECG comparison in older adults.
This piece covers a study designed to test self-administered pulse palpation for atrial fibrillation screening in patients 65 and older, run alongside handheld ECG readings. It does not cover the specific sensitivity or specificity of pulse palpation compared with ECG, figures not available in the source material for this piece.
European cardiology guidelines have long recommended checking your own pulse as a valid, single-time-point way to screen for atrial fibrillation, a Class IA recommendation, even though that recommendation had not actually been tested against ECG readings until researchers set out to do exactly that. In patients 65 and older screened over two weeks using handheld ECG alongside self-taught pulse checks, the combined approach identified new AFib cases in a meaningful share of participants, most of whom were then able to start anticoagulant treatment. That comparison ran in 2020.
A guideline that had never actually been checked
Feeling for an irregular pulse is the oldest, cheapest form of AFib screening there is, and it's built into official cardiology guidance as a legitimate single-time-point check. What's easy to miss is that this specific recommendation, endorsed at the highest guideline grade, had gone unvalidated against an actual ECG reading for years before anyone ran that comparison directly.
Researchers in patients 65 and older finally did, pairing a period of self-taught pulse checks with simultaneous handheld ECG recordings rather than treating the guideline recommendation as settled.
1 study
- European Society of Cardiology guidelines recommend single-time-point AFib screening via pulse palpation at the highest evidence grade, Class IA, despite this specific recommendation not having been validated against ECG recordings. A study in 1,010 patients aged 65 and older at four primary care centers paired self-taught pulse checks with handheld ECG readings taken three times daily for two weeks, identifying 27 new AFib cases, 2.7% of participants, of whom 96% were then able to start anticoagulant treatment.
What the study actually measured, and what it doesn't hand you
The explicit purpose here was to compare the validity of self-pulse palpation against a simultaneous ECG reading, not just to run a screening program and count new diagnoses. That distinction matters, this wasn't a test of ECG screening alone, it was built specifically around teaching ordinary patients to check their own pulse and testing that approach against a device reading taken at the same moment.
What the yield numbers do show clearly is that combining the two approaches over two weeks in an older population found real, previously undetected AFib cases at a rate high enough to change treatment for most of them. How wearable ECGs perform against a clinical reference is a related but separate accuracy question from what pulse palpation itself achieves on its own.
The gap this piece can't close
The specific figure most people actually want, how often self-pulse-palpation alone agreed with the same-moment ECG reading, isn't part of the material available for this piece. What's confirmed is the guideline's high-grade endorsement of pulse palpation, the explicit purpose behind testing it, and the combined screening approach's overall yield in this population.
Community AFib screening more broadly is still described in the review literature as an area with promising observational and trial evidence, including randomized trials suggesting benefits in stroke reduction. But without definitive consensus on the best approach.
This piece does not include the specific sensitivity or specificity figures comparing self-pulse palpation directly against the simultaneous ECG readings in the Ghazal study; only the study's design, its explicit purpose, and its overall two-week screening yield are part of the evidence available here.
Common questions
Is checking your own pulse an officially recommended way to screen for AFib?
European Society of Cardiology guidelines recommend single-time-point pulse palpation for AFib screening at their highest evidence grade, Class IA, though this specific recommendation had not been directly validated against ECG before a dedicated study tested it.
How many new AFib cases did the pulse-and-ECG screening study find?
Among 1,010 patients aged 65 and older screened over two weeks using both self-taught pulse checks and handheld ECG readings, 27 new AFib cases were identified, and 96% of those patients were able to start anticoagulant treatment.
Does this tell us how accurate pulse palpation is on its own compared to ECG?
The study was explicitly designed to test that comparison, but the specific accuracy figures for pulse palpation alone against the same-moment ECG readings are not part of the material available for this piece.
Is community AFib screening generally considered settled science?
According to review literature on community-level screening, randomized trials have suggested benefits such as stroke reduction, but the field describes a lack of definitive consensus on the best screening approach overall.